Health Canada has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. The…
Fatty liver disease
FATTY LIVER DISEASE
NewsFDA authorizes use of 1st AI tool to speed MASH clinical trials
The U.S. Food and Drug Administration (FDA) has authorized the use of the first artificial intelligence (AI) drug-development tool for use in clinical trials of metabolic…
FATTY LIVER DISEASE
ColumnsStaying on top of MASH may mean not staying on the transplant list
The past two months have been a whirlwind. I had my left knee replaced in late October, which forced me to slow down and truly…
FATTY LIVER DISEASE
NewsLower-cost TAEUS device tracks liver fat on par with gold standard
TAEUS, a diagnostic tool being developed by Endra Life Sciences, measures liver fat levels with similar accuracy to gold-standard tests, but with greater convenience…
FATTY LIVER DISEASE
ColumnsWith MASH, it’s important to be aware of liver cancer risk factors
A few years ago, I had a frightening visit with my doctor. I’d just moved into my new house and changed my cellphone number, and…
FATTY LIVER DISEASE
NewsToo much sorbitol may raise fatty liver disease risk, study finds
Excessive intake of sorbitol, a type of sugar naturally found in many fruits and used as a sugar substitute, may increase the risk of metabolic…
FATTY LIVER DISEASE
ColumnsAccess to food is a survival tactic when your liver needs nutrition
Growing up in a dusty Utah town, my life looked nothing like the one I lead today. My parents worked hard, but the early 1980s…
FATTY LIVER DISEASE
NewsBelapectin may help reduce liver scarring in those with severe MASH
Galectin Therapeutics‘ experimental medication belapectin may help reduce liver scarring, or fibrosis, and lower the risk of blood vessel complications in people with metabolic-associated…
FATTY LIVER DISEASE
ColumnsThis fatty liver disease diagnosis reminded me heroes are human
When I was a teenager, I fell in love with football. Growing up in Utah, a place that still doesn’t have an NFL franchise, meant…
FATTY LIVER DISEASE
NewsRezdiffra reduces liver scarring in high-risk MASH patients: Trial data
Long-term treatment with Rezdiffra (resmetirom) reduces liver scarring and other signs of advanced disease in adults with high-risk compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis…
Recent Posts
- Don’t let living with MASH stop you from your New Year’s goals
- Frequent bile acid level checks urged to predict stillbirth in severe ICP
- Wegovy cleared in Canada to treat fatty liver disease MASH
- Medications known as IBATIs are safe, effective in Alagille: Analysis
- New rapid test could accelerate hepatitis C diagnosis and treatment